Decitabine in chronic leukemias

JPJ Issa, JC Byrd - Seminars in hematology, 2005 - Elsevier
5-Aza-2′-deoxycitidine (decitabine, Dacogen™, Bloomington, MN) is a cytosine analogue
that promotes hypomethylation of DNA and has documented efficacy in myeloid …
被引用次数：25 相关文章

Decitabine in chronic leukemias

JPJ Issa, JC Byrd - Seminars in hematology, 2005 - pubmed.ncbi.nlm.nih.gov
5-Aza-2'-deoxycitidine (decitabine, Dacogen, Bloomington, MN) is a cytosine analogue that
promotes hypomethylation of DNA and has documented efficacy in myeloid malignancies …

Decitabine in chronic leukemias

JPJ Issa, JC Byrd - Seminars in Hematology, 2005 - ohiostate.elsevierpure.com
Aza-2′-deoxycitidine (decitabine, Dacogen™, Bloomington, MN) is a cytosine analogue
that promotes hypomethylation of DNA and has documented efficacy in myeloid …

[引用][C] Decitabine in chronic leukemias

JPJ ISSA, JC BYRD - Seminars in hematology, 2005 - pascal-francis.inist.fr
Decitabine in chronic leukemias CNRS Inist Pascal-Francis CNRS Pascal and Francis
Bibliographic Databases Simple search Advanced search Search by classification Search …

Decitabine in Chronic Leukemias

JPJ Issa, JC Byrd - Seminars in Hematology, 2005 - infona.pl
5-Aza-2′-deoxycitidine (decitabine, Dacogen™, Bloomington, MN) is a cytosine analogue
that promotes hypomethylation of DNA and has documented efficacy in myeloid …

Decitabine in chronic leukemias.

JP Issa, JC Byrd - Seminars in Hematology, 2005 - europepmc.org
5-Aza-2'-deoxycitidine (decitabine, Dacogen, Bloomington, MN) is a cytosine analogue that
promotes hypomethylation of DNA and has documented efficacy in myeloid malignancies …

[引用][C] Decitabine in chronic leukemias

JPJ ISSA, JC BYRD - Seminars in hematology, 2005 - Elsevier